Archive for December, 2015

Boston Private Financial Hldg Inc (NASDAQ:BPFH) Receives $14.07 Average PT …

Share on StockTwits

Shares of Boston Private Financial Hldg Inc (NASDAQ:BPFH) have been assigned a consensus rating of “Hold” from the nine ratings firms that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $14.07.

Several analysts have issued reports on the stock. Keefe, Bruyette Woods cut their target price on shares of Boston Private Financial Hldg from $12.50 to $12.00 in a research note on Friday, October 23rd. RBC Capital dropped their price target on shares of Boston Private Financial Hldg from $13.00 to $12.00 and set a “sector perform” rating on the stock in a research note on Friday, October 23rd. FIG Partners downgraded shares of Boston Private Financial Hldg from an “outperform” rating to a “market perform” rating in a research note on Thursday, October 22nd. Zacks Investment Research downgraded shares of Boston Private Financial Hldg from a “buy” rating to a “hold” rating in a research note on Thursday, October 8th. Finally, Jefferies Group dropped their price target on shares of Boston Private Financial Hldg from $14.50 to $13.00 and set a “buy” rating on the stock in a research note on Tuesday, October 6th.

In related news, insider Peter J. Raimondi sold 110,000 shares of the stock in a transaction dated Wednesday, December 2nd. The shares were sold at an average price of $12.05, for a total value of $1,325,500.00. Following the completion of the sale, the insider now owns 401,877 shares in the company, valued at $4,842,617.85. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Martha Higgins sold 4,446 shares of the stock in a transaction dated Thursday, December 10th. The shares were sold at an average price of $11.20, for a total transaction of $49,795.20. Following the completion of the sale, the executive vice president now owns 54,191 shares of the company’s stock, valued at approximately $606,939.20. The disclosure for this sale can be found here.

Shares of Boston Private Financial Hldg (NASDAQ:BPFH) opened at 11.46 on Monday. Boston Private Financial Hldg has a 12 month low of $10.55 and a 12 month high of $13.82. The stock has a market capitalization of $958.65 million and a price-to-earnings ratio of 15.92. The stock’s 50 day moving average price is $11.59 and its 200-day moving average price is $12.16.

Boston Private Financial Hldg (NASDAQ:BPFH) last announced its earnings results on Wednesday, October 21st. The company reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by $0.04. The business had revenue of $85.90 million for the quarter, compared to the consensus estimate of $47.46 million. During the same quarter in the prior year, the business posted $0.22 earnings per share. Equities analysts forecast that Boston Private Financial Hldg will post $0.76 earnings per share for the current fiscal year.

Boston Private Financial Holdings, Inc. is the bank holding company of Boston Private Bank Trust Company. It is a wealth management company that offers a range of wealth management services to high net worth individuals, families, businesses, and select institutions. The Company conducts its business through its four segments: Private Banking, Wealth Management and Trust, Investment Management and Wealth Advisory. The Private Banking segment is engaged in providing private banking services to high net worth individuals, privately owned businesses, private partnerships, and nonprofit organizations. The Wealth Management and Trust segment provides wealth management solutions for high net worth individuals and families. The Investment Managers specialize in equity portfolios with products across the capitalization spectrum. The Wealth Advisory segment provides planning-based financial strategies to high net worth individuals and their families and non-profit institutions.

This story was originally published by Putnam Standard (http://putnamstandard.com) and is the sole property of Putnam Standard. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://putnamstandard.com/2015/12/28/boston-private-financial-hldg-inc-nasdaqbpfh-receives-14-07-average-pt-from-brokerages/707678/


Tags:

Monday, December 28th, 2015 EN No Comments

Eagle Asset Management Purchases $97022000 in ConocoPhillips (COP) Shares

Eagle Asset Management boosted its position in shares of ConocoPhillips (NYSE:COP) by 107.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,023,004 shares of the company’s stock after buying an additional 1,047,248 shares during the period. Eagle Asset Management owned 0.16% of ConocoPhillips worth $97,022,000 as of its most recent SEC filing.

Separately, Modera Wealth Management increased its position in ConocoPhillips by 0.6% in the third quarter. Modera Wealth Management now owns 4,522 shares of the company’s stock valued at $217,000 after buying an additional 29 shares in the last quarter.

ConocoPhillips (NYSE:COP) opened at 48.59 on Monday. The company has a 50-day moving average of $51.52 and a 200-day moving average of $53.06. ConocoPhillips has a one year low of $41.10 and a one year high of $70.79. The stock’s market capitalization is $59.99 billion.


ConocoPhillips (NYSE:COP) last issued its earnings results on Thursday, October 29th. The company reported ($0.38) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.38). During the same quarter in the previous year, the business earned $1.29 EPS. On average, equities analysts forecast that ConocoPhillips will post ($0.88) EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 1st. Stockholders of record on Monday, October 19th were given a dividend of $0.74 per share. This represents a $2.96 dividend on an annualized basis and a dividend yield of 6.09%. The ex-dividend date was Thursday, October 15th.

COP has been the topic of a number of research analyst reports. JPMorgan Chase Co. reduced their price target on ConocoPhillips from $47.00 to $45.00 and set an “underweight” rating on the stock in a report on Tuesday, December 15th. Credit Agricole initiated coverage on ConocoPhillips in a report on Tuesday, December 15th. They set an “outperform” rating on the stock. CLSA restated an “outperform” rating on shares of ConocoPhillips in a report on Tuesday, December 15th. Howard Weil reduced their price target on ConocoPhillips from $59.00 to $55.00 in a report on Monday, December 14th. Finally, Credit Suisse reduced their price target on ConocoPhillips from $56.00 to $53.00 and set a “neutral” rating on the stock in a report on Friday, December 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $61.70.

In related news, Director Arjun N. Murti acquired 5,000 shares of the stock in a transaction dated Wednesday, December 16th. The stock was acquired at an average cost of $49.90 per share, for a total transaction of $249,500.00. Following the completion of the purchase, the director now owns 5,000 shares of the company’s stock, valued at approximately $249,500. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Jeffrey Wayne Sheets sold 15,746 shares of ConocoPhillips stock in a transaction on Thursday, November 19th. The stock was sold at an average price of $54.00, for a total transaction of $850,284.00. Following the sale, the chief financial officer now owns 24,636 shares of the company’s stock, valued at $1,330,344. The disclosure for this sale can be found here.

ConocoPhillips (NYSE:COP) is an independent exploration and production company. The Company explores for, produces, transports and markets crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids. The Company operates through six operating segments, which are primarily defined by geographic region: Alaska, Lower 48, Canada, Europe, Asia Pacific and Middle East, and Other International. The Company’s continuing operations are producing in the United States, Norway, the United Kingdom, Canada, Australia, Timor-Leste, Indonesia, China, Malaysia, Qatar, Libya and Russia. The Company has major ownership interests in two of North America’s oil fields located on Alaska’s North Slope: Prudhoe Bay and Kuparuk.

This story was originally published by Dakota Financial News (http://www.dakotafinancialnews.com) and is the sole property of Dakota Financial News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.dakotafinancialnews.com/eagle-asset-management-purchases-97022000-in-conocophillips-cop-shares/765993/

Receive News Ratings for ConocoPhillips Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ConocoPhillips and related companies with MarketBeat.com’s FREE daily email newsletter.

<!– –>

Tags:

Monday, December 28th, 2015 EN No Comments

Northcoast Asset Management Eliminates Stake in Bank of Montreal (BMO)

Northcoast Asset Management eliminated its stake in shares of Bank of Montreal (NYSE:BMO) during the third quarter, according to its most recent 13F filing with the SEC. The firm previously had a 22,027 share stake in the company, valued at approximately $1,251,133. Northcoast Asset Management was fully divested from the company by the time it had filed its most recent disclosure.

Shares of Bank of Montreal (NYSE:BMO) opened at 56.80 on Friday. Bank of Montreal has a 12 month low of $48.17 and a 12 month high of $71.08. The firm has a 50-day moving average of $57.35 and a 200-day moving average of $56.73. The company has a market capitalization of $36.52 billion and a P/E ratio of 11.98.

Bank of Montreal (NYSE:BMO) last announced its earnings results on Tuesday, December 1st. The company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.16. The business had revenue of $4.72 billion for the quarter. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the business earned $1.63 EPS. On average, equities analysts predict that Bank of Montreal will post $7.23 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 26th. Investors of record on Monday, February 1st will be given a dividend of $0.6318 per share. The ex-dividend date is Thursday, January 28th. This represents a $2.53 annualized dividend and a yield of 4.45%.

BMO has been the topic of several research reports. Zacks Investment Research upgraded shares of Bank of Montreal from a “sell” rating to a “hold” rating in a report on Tuesday, October 13th. Barclays dropped their price objective on shares of Bank of Montreal from $73.00 to $72.00 and set an “underweight” rating on the stock in a report on Thursday, September 10th. Scotiabank reissued a “sector perform” rating and set a $78.00 target price on shares of Bank of Montreal in a research report on Sunday, September 13th. CIBC reissued a “sector perform” rating on shares of Bank of Montreal in a research report on Sunday, September 13th. Finally, Credit Suisse boosted their target price on shares of Bank of Montreal from $93.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, December 17th. One analyst has rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. Bank of Montreal presently has a consensus rating of “Hold” and a consensus target price of $81.08.

Bank of Montreal (NYSE:BMO) is a financial services company. The Bank provides a range of retail banking, wealth management, and investment banking products and services. It conducts its business through three operating groups: Personal and Commercial Banking, Wealth Management and BMO Capital Markets. The Bank operates primarily in Canada and the United States. It also has operations in the United Kingdom, Europe, the Caribbean and Asia. It also serves customers through its wealth management businesses: BMO Nesbitt Burns, BMO InvestorLine, BMO Private Banking, BMO Global Asset Management and BMO Insurance. BMO Capital Markets, its investment and corporate banking and trading products division, provides a suite of financial products and services to North American and international clients. In the United States, BMO serves customers through BMO Harris Bank, based in the United States Midwest with more than two million retail, small business and commercial customers.document.write(‘‘);

This story was originally published by Storm Investor (http://www.storminvestor.com) and is the sole property of Storm Investor. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.storminvestor.com/northcoast-asset-management-eliminates-stake-in-bank-of-montreal-bmo/209366/

Receive News Ratings for Bank of Montreal Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bank of Montreal and related companies with MarketBeat.com’s FREE daily email newsletter.


<!—->

Tags:

Sunday, December 27th, 2015 EN No Comments

Northcoast Asset Management Sells Position in RBC Capital (RY)

Northcoast Asset Management closed out its position in shares of RBC Capital (NYSE:RY) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm previously had a 109,030 share position in the company, valued at approximately $5,949,767. Northcoast Asset Management was fully divested from the company by the time it had filed its quarterly disclosure with the SEC.

RBC Capital (NYSE:RY) opened at 54.57 on Friday. The firm has a market cap of $81.04 billion and a price-to-earnings ratio of 11.24. The company has a 50-day moving average of $55.77 and a 200 day moving average of $57.37. RBC Capital has a 12-month low of $51.27 and a 12-month high of $69.87.

RBC Capital (NYSE:RY) last issued its quarterly earnings results on Wednesday, December 2nd. The company reported $1.74 EPS for the quarter, topping the Zacks’ consensus estimate of $1.64 by $0.10. The company earned $8.02 billion during the quarter, compared to the consensus estimate of $8.56 billion. RBC Capital’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.57 EPS. Equities analysts expect that RBC Capital will post $6.93 EPS for the current fiscal year.

A number of analysts have weighed in on the stock. National Bank Financial reaffirmed a “sector perform” rating and set a $79.00 target price (up previously from $76.00) on shares of RBC Capital in a research note on Friday, December 4th. Zacks Investment Research raised shares of RBC Capital from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research note on Wednesday, October 28th. Bank of America reaffirmed a “buy” rating and set a $92.00 target price (down previously from $93.00) on shares of RBC Capital in a research note on Friday, December 4th. Credit Suisse raised shares of RBC Capital to a “buy” rating in a research note on Tuesday, October 27th. Finally, Barclays decreased their target price on shares of RBC Capital from $74.00 to $71.00 and set an “underweight” rating on the stock in a research note on Thursday, September 10th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the stock. RBC Capital currently has an average rating of “Hold” and an average price target of $80.09.

Royal Bank of Canada (NYSE:RY) is a diversified financial services company. The Company provides personal and commercial banking, wealth management services, insurance, investor services and capital markets products and services on a global basis. It operates in five segments: Personal Commercial Banking, which operates comprises its personal and business banking operations, as well as its auto financing and retail investment businesses; Wealth Management, which comprises Canadian Wealth Management, United States and International Wealth Management and Global Asset Management (GAM); Insurance, which operates under two business lines: Canadian Insurance and International Insurance; Investor Treasury Services, which is a provider of asset servicing, custody, payments and treasury services, and Capital Markets, which comprises two business lines: Corporate and Investment Banking and Global Markets. It operates in three geographic segments: Canada, United States and Other International.

This story was originally published by Storm Investor (http://www.storminvestor.com) and is the sole property of Storm Investor. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.storminvestor.com/northcoast-asset-management-sells-position-in-rbc-capital-ry/209360/

Receive News Ratings for RBC Capital Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for RBC Capital and related companies with MarketBeat.com’s FREE daily email newsletter.


<!—->

Tags:

Sunday, December 27th, 2015 EN No Comments

Colgate-Palmolive Company (CL) Earns "AA" Credit Rating from Morningstar

Share on StockTwits

Colgate-Palmolive Company (NYSE:CL) has received an “AA” credit rating from analysts at Morningstar. The firm’s “AA” rating indicates that the company is a very-low default risk. They also gave their stock a four star rating.

A number of other research analysts also recently issued reports on CL. B. Riley restated a “neutral” rating and issued a $75.00 price target on shares of Colgate-Palmolive Company in a research report on Monday, November 2nd. BNP Paribas dropped their price target on shares of Colgate-Palmolive Company to $68.00 in a research report on Monday, November 23rd. TheStreet lowered shares of Colgate-Palmolive Company from a “buy” rating to a “hold” rating in a research note on Friday, October 30th. Canaccord Genuity reiterated a “hold” rating and issued a $65.00 price objective on shares of Colgate-Palmolive Company in a research note on Friday, October 30th. Finally, Argus upgraded shares of Colgate-Palmolive Company from a “hold” rating to a “buy” rating in a research note on Thursday, November 26th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $71.00.

Other institutional investors recently added to or reduced their stakes in the company. ING Groep increased its position in shares of Colgate-Palmolive Company by 14.1% in the third quarter. ING Groep now owns 106,105 shares of the company’s stock valued at $6,737,000 after buying an additional 13,137 shares during the period. Perigon Wealth Management increased its position in shares of Colgate-Palmolive Company by 2.1% in the third quarter. Perigon Wealth Management now owns 13,103 shares of the company’s stock valued at $832,000 after buying an additional 268 shares during the period. Gerstein Fisher increased its position in shares of Colgate-Palmolive Company by 35.8% in the third quarter. Gerstein Fisher now owns 7,092 shares of the company’s stock valued at $450,000 after buying an additional 1,869 shares during the period. Finally, Modera Wealth Management increased its position in shares of Colgate-Palmolive Company by 14.4% in the third quarter. Modera Wealth Management now owns 4,769 shares of the company’s stock valued at $303,000 after buying an additional 600 shares during the period.

Shares of Colgate-Palmolive Company (NYSE:CL) opened at 66.99 on Friday. Colgate-Palmolive Company has a 12-month low of $50.84 and a 12-month high of $71.56. The firm’s 50-day moving average is $66.22 and its 200 day moving average is $65.94. The stock has a market capitalization of $60.08 billion and a P/E ratio of 24.80.

Colgate-Palmolive Company (NYSE:CL) last released its quarterly earnings data on Friday, October 30th. The company reported $0.72 EPS for the quarter, hitting the consensus estimate of $0.72. The business earned $4 billion during the quarter, compared to the consensus estimate of $4.08 billion. During the same quarter in the previous year, the business posted $0.76 earnings per share. Colgate-Palmolive Company’s quarterly revenue was down 8.7% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive Company will post $2.79 EPS for the current fiscal year.

Colgate-Palmolive Company (NYSE:CL) is a consumer products company, whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes, among others. The Company sells its personal care products under the Palmolive, Protex and Softsoap brands. The Company, through its Hill’s Pet Nutrition segment (Hill’s), manufactures pet nutrition products for dogs and cats.

To view more credit ratings from Morningstar, visit www.jdoqocy.comclick-7674909-10651170.

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/980805/colgate-palmolive-company-cl-earns-aa-credit-rating-from-morningstar-2/

Receive News Ratings for Colgate-Palmolive Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive Company and related companies with MarketBeat.com’s FREE daily email newsletter.

Tags:

Sunday, December 27th, 2015 EN No Comments

General Electric Company (GE) Shares Bought by Modera Wealth Management

Ukraine imposes moratorium on payment of Russian debt

United not as ‘glum’ as during Moyes’ tenure – Jones

Iraq warns IS-held Ramadi residents to leave city within 72 hours

9 more Syrian refugees cleared to come to Houston

Pentagon chief’s use of private email inconsistent with policy: White House

Hernandez grateful to Ferguson for giving him United chance

Panthers’ Rivera: No more bat on field

SpaceX lands a rocket

Investigation needed into ‘torture’ claims of Thailand backpacker murderers

Idaho School District Offers Lunch Worker Her Job Back

U.S. defence chief Carter makes surprise visit to Baghdad

Lunch lady fired for giving free meal to child, offered job back

Clinton Calls For ‘Manhattan-like Project’ To Track Terrorists Through

Louisa Johnson’s debut single ALREADY number one less than 24 hours after

​Dier makes no excuses as Tottenham fall to lowly Newcastle

Tags:

Saturday, December 26th, 2015 EN No Comments

Sherman named Five Star Professional

Steve Sherman

Steve Sherman

Morgan Stanley announced Dec. 1 that Wilton resident Steve Sherman, a financial adviser in the firm’s Westport office, has been named a 2015 Five Star Professional Wealth Manager.

Each year, this Connecticut Magazine award recognizes a select group of wealth managers in the tri-state area. Sherman’s award will be featured in the monthly magazine’s December issue.

“I am extremely proud Steve Sherman is representing Morgan Stanley on this list,” said complex manager Bradley Barber. “This listing recognizes the top wealth managers in the tri-state area who are committed to providing exceptional wealth management services to clients.”

Morgan Stanley is a global financial services firm providing investment banking, securities, wealth management and investment management services.

Tags:

Saturday, December 26th, 2015 EN No Comments

ING Groep Buys $9729000 Shares of McKesson Co. (MCK)

ING Groep bought a new position in shares of McKesson Co. (NYSE:MCK) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 52,604 shares of the company’s stock, valued at approximately $9,729,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Perigon Wealth Management raised its position in McKesson by 3.6% in the third quarter. Perigon Wealth Management now owns 1,312 shares of the company’s stock worth $243,000 after buying an additional 45 shares during the last quarter. Northcoast Asset Management acquired a new position in McKesson during the third quarter worth approximately $980,000. Finally, Jennison Associates raised its position in McKesson by 0.4% in the third quarter. Jennison Associates now owns 383,659 shares of the company’s stock worth $70,988,000 after buying an additional 1,416 shares during the last quarter.

McKesson Co. (NYSE:MCK) opened at 199.41 on Friday. McKesson Co. has a 52-week low of $160.10 and a 52-week high of $243.61. The company has a market capitalization of $45.89 billion and a PE ratio of 26.09. The company has a 50-day moving average price of $188.97 and a 200 day moving average price of $204.32.


McKesson (NYSE:MCK) last announced its quarterly earnings data on Thursday, October 29th. The company reported $3.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.99 by $0.32. During the same period in the previous year, the business earned $2.79 EPS. The firm earned $48.60 billion during the quarter, compared to the consensus estimate of $47.85 billion. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities research analysts anticipate that McKesson Co. will post $12.85 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be paid a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Friday, November 27th.

A number of research analysts have commented on MCK shares. Robert W. Baird lowered their price target on McKesson from $260.00 to $239.00 in a research report on Friday, October 30th. Mizuho reaffirmed a “buy” rating and set a $275.00 price target on shares of McKesson in a research report on Monday, September 21st. Goldman Sachs lowered McKesson from a “conviction-buy” rating to a “buy” rating and lowered their price target for the company from $241.00 to $210.00 in a research report on Wednesday, November 4th. Cowen and Company lowered their price target on McKesson from $254.00 to $237.00 in a research report on Wednesday, October 21st. Finally, Barclays reduced their target price on McKesson from $245.00 to $220.00 and set an “overweight” rating on the stock in a report on Monday, November 2nd. One investment analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $235.43.

In other news, CEO John H. Hammergren sold 56,533 shares of McKesson stock in a transaction that occurred on Tuesday, November 24th. The shares were sold at an average price of $190.01, for a total transaction of $10,741,835.33. The transaction was disclosed in a filing with the Securities Exchange Commission, which is available at this link.

McKesson Corporation (NYSE:MCK) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

This story was originally published by Dakota Financial News (http://www.dakotafinancialnews.com) and is the sole property of Dakota Financial News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.dakotafinancialnews.com/ing-groep-buys-9729000-shares-of-mckesson-co-mck/764806/

Receive News Ratings for McKesson Co. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for McKesson Co. and related companies with MarketBeat.com’s FREE daily email newsletter.

<!– –>

Tags:

Saturday, December 26th, 2015 EN No Comments

General Electric Company (GE) PT Raised to $36.00 at Argus

Share on StockTwits

General Electric Company (NYSE:GE) had its price objective hoisted by research analysts at Argus from $34.00 to $36.00 in a research report issued to clients and investors on Wednesday, MarketBeat Ratings reports. The firm presently has a “buy” rating on the stock. Argus’ price target would suggest a potential upside of 16.77% from the company’s previous close.

Other large investors recently bought and sold shares of the company. Perigon Wealth Management increased its stake in General Electric Company by 11.3% in the third quarter. Perigon Wealth Management now owns 63,884 shares of the company’s stock valued at $1,615,000 after buying an additional 6,501 shares during the period. Gerstein Fisher increased its stake in General Electric Company by 4.0% in the third quarter. Gerstein Fisher now owns 67,769 shares of the company’s stock valued at $1,709,000 after buying an additional 2,581 shares during the last quarter. Modera Wealth Management increased its stake in General Electric Company by 7.7% in the third quarter. Modera Wealth Management now owns 31,574 shares of the company’s stock valued at $796,000 after buying an additional 2,247 shares during the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft acquired a new stake in General Electric Company during the third quarter valued at approximately $3,186,000. Finally, Chelsea Counsel Company increased its stake in General Electric Company by 0.4% in the third quarter. Chelsea Counsel Company now owns 282,377 shares of the company’s stock valued at $7,122,000 after buying an additional 1,000 shares during the last quarter.

General Electric Company (NYSE:GE) opened at 30.83 on Wednesday. General Electric Company has a 52 week low of $19.37 and a 52 week high of $31.23. The company’s 50-day moving average price is $30.35 and its 200 day moving average price is $27.46. The company’s market capitalization is $311.67 billion.

General Electric Company (NYSE:GE) last posted its quarterly earnings data on Friday, October 16th. The company reported $0.32 EPS for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.06. The business had revenue of $26.55 billion for the quarter. General Electric Company’s revenue was down 2.1% on a year-over-year basis. During the same period last year, the company posted $0.38 EPS. On average, analysts predict that General Electric Company will post $1.29 EPS for the current year.

A number of other equities analysts also recently commented on the stock. Independent Research GmbH restated a “buy” rating and set a $37.00 price objective on shares of General Electric Company in a research note on Friday, December 18th. Stifel Nicolaus reiterated a “buy” rating on shares of General Electric Company in a research note on Thursday, December 17th. Societe Generale reiterated a “neutral” rating and issued a $31.00 target price on shares of General Electric Company in a research note on Monday, December 7th. RBC Capital raised their target price on shares of General Electric Company from $32.00 to $34.00 and gave the company an “outperform” rating in a research note on Monday, November 30th. Finally, Vetr upgraded shares of General Electric Company from a “hold” rating to a “buy” rating and set a $32.26 target price for the company in a research note on Monday, November 23rd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $31.18.

General Electric Company (NYSE:GE) is a diversified infrastructure and financial services company. The products and services of the Company range from aircraft engines, power generation, oil and gas production equipment, and household appliances to medical imaging, business and consumer financing and industrial products. The Company operates its segments through its eight businesses, -based on the markets they serve: Power Water, Oil Gas, Energy Management, Aviation, Healthcare, Transportation, Appliances, and Lighting and GE Capital. GE Capital operates the following businesses: Commercial Lending and Leasing, Consumer, Real Estate, Energy Financial Services and GE Capital Aviation Services. The Company operates in approximately 175 countries.

This story was originally published by MidSouth Newz (http://midsouthnewz.com) and is the sole property of MidSouth Newz. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://midsouthnewz.com/general-electric-company-ge-pt-raised-to-36-00-at-argus/89081/

Receive News Ratings for General Electric Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for General Electric Company and related companies with MarketBeat.com’s FREE daily email newsletter.

Tags:

Friday, December 25th, 2015 EN No Comments

Modera Wealth Management Has $328000 Position in Merck & Co., Inc. (MRK)

Share on StockTwits

Modera Wealth Management reduced its stake in shares of Merck Co., Inc. (NYSE:MRK) by 0.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,640 shares of the company’s stock after selling 42 shares during the period. Modera Wealth Management’s holdings in Merck Co. were worth $328,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Jennison Associates acquired a new position in Merck Co. during the third quarter valued at about $32,104,000. Meag Munich Ergo Kapitalanlagegesellschaft increased its position in Merck Co. by 69.2% in the third quarter. Meag Munich Ergo Kapitalanlagegesellschaft now owns 422,780 shares of the company’s stock valued at $20,830,000 after buying an additional 172,961 shares during the last quarter. Finally, Baker Avenue Asset Management increased its position in Merck Co. by 28.4% in the third quarter. Baker Avenue Asset Management now owns 13,873 shares of the company’s stock valued at $685,000 after buying an additional 3,065 shares during the last quarter.

Merck Co., Inc. (NYSE:MRK) opened at 52.85 on Friday. Merck Co., Inc. has a 1-year low of $45.69 and a 1-year high of $63.62. The company has a market capitalization of $147.64 billion and a price-to-earnings ratio of 14.02. The firm has a 50 day moving average of $53.43 and a 200-day moving average of $54.77.

Merck Co. (NYSE:MRK) last posted its quarterly earnings results on Tuesday, October 27th. The company reported $0.96 EPS for the quarter, beating the Zacks’ consensus estimate of $0.91 by $0.05. The firm had revenue of $10.10 billion for the quarter, compared to the consensus estimate of $10.11 billion. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.90 earnings per share. On average, equities research analysts anticipate that Merck Co., Inc. will post $3.57 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.46 per share. This is a positive change from Merck Co.’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend is Friday, December 11th. This represents a $1.84 dividend on an annualized basis and a yield of 3.48%.

Several equities analysts have recently issued reports on the stock. Vetr downgraded shares of Merck Co. from a “strong-buy” rating to a “buy” rating and set a $59.46 price target for the company. in a research note on Tuesday, November 24th. Jefferies Group increased their price objective on shares of Merck Co. to $55.00 and gave the stock a “hold” rating in a research report on Wednesday, November 18th. Berenberg Bank started coverage on shares of Merck Co. in a research report on Tuesday, November 24th. They set a “hold” rating and a $61.00 price objective for the company. Atlantic Securities started coverage on shares of Merck Co. in a research report on Friday, December 18th. They set a “neutral” rating for the company. Finally, Leerink Swann reiterated a “market perform” rating and set a $67.00 price objective on shares of Merck Co. in a research report on Monday, October 26th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the stock. Merck Co. has an average rating of “Hold” and an average price target of $63.27.

In other news, Director Wendell P. Weeks sold 5,000 shares of the company’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $55.53, for a total value of $277,650.00. Following the sale, the director now directly owns 100 shares of the company’s stock, valued at approximately $5,553. The transaction was disclosed in a legal filing with the Securities Exchange Commission, which can be accessed through this link. Also, insider Adele D. Ambrose sold 37,313 shares of the company’s stock in a transaction dated Thursday, October 29th. The stock was sold at an average price of $55.08, for a total transaction of $2,055,200.04. Following the completion of the sale, the insider now directly owns 19,695 shares in the company, valued at $1,084,800.60. The disclosure for this sale can be found here.

Merck Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. The Company’s animal health products are sold to veterinarians, distributors and animal producers.

This story was originally published by MidSouth Newz (http://midsouthnewz.com) and is the sole property of MidSouth Newz. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://midsouthnewz.com/modera-wealth-management-has-328000-position-in-merck-co-inc-mrk/88854/

Receive News Ratings for Merck Co. Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Merck Co. Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Tags:

Friday, December 25th, 2015 EN No Comments